lobbying_activities: 2959078

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2959078	39aa04f7-e991-42f1-a3b9-beb034ed1208	Q1	AARP	1694	AARP	2023	first_quarter	PHA	S.79, Interagency Patent Coordination and Improvement Act of 2023. S.113, Prescription Pricing for the People Act of 2023. S.142, Preserve Access to Affordable Generics and Biosimilars Act of 2023. S.148, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop (STALLING) Act. S.150, Affordable Prescriptions for Patients Act of 2023. S.935, the Fair Accountability and Innovative Research (FAIR) Drug Pricing Act of 2023. No bill number. Discussed Medicare prescription drug inflation rebate program. No bill number. Discussed proposed Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies. No bill number. Discussed proposed Contract Year 2024 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit Program (Part D). H.R.485, Protecting Health Care for All Patients Act of 2023. No bill number. Discussed Drug-Price Transparency for Consumers (DTC) Act of 2023. No bill number. Discussed Biosimilar Red Tape Elimination Act. No bill number. Discussed Protecting Consumer Access to Generic Drugs Act. No bill number. Discussed federal prescription drug pricing. No bill number. Discussed insulin prices. No bill number. Discussed out of pocket cost smoothing in Part D. No bill number. Discussed prescription drug access and prices.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office		3850000	0	0	2023-04-14T08:31:06-04:00